Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Pierre Blier

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Occupations

Electrophysiology

Physiology

Synaptic Transmission

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
76
de Montigny, Claude
19
Haddjeri, Nasser
17
Debonnel, Guy
13
El Mansari, Mostafa
10
Szabo, Steven
8
Chaput, Yves
8
Benkelfat, Chawki
7
Diksic, Mirko
6
Béïque, Jean-Claude
6
Leyton, Marco
6
Hen, René
6
Young, Simon
5
Rueter, LE
5
Gobbi, Gabriella
4
Hébert, Chantal

Sign-in to see all Coauthors

Publications

TOP 3
Chernoloz Olga; El Mansari Mostafa; Blier Pierre
Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.
Chenu Franck; Batten Lisa A; Zernig Gerald; Ladstaetter Elisabeth; Hébert Chantal; Blier Pierre
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.
Manta Stella; Dong Jianming; Debonnel Guy; Blier Pierre
Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Pierre Blier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Chernoloz Olga; El Mansari Mostafa; Blier Pierre
Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.
Psychopharmacology 2009;206(2):335-44.
2009: Chenu Franck; Batten Lisa A; Zernig Gerald; Ladstaetter Elisabeth; Hébert Chantal; Blier Pierre
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.
The Journal of clinical psychiatry 2009;70(7):958-66.
2009: Manta Stella; Dong Jianming; Debonnel Guy; Blier Pierre
Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation.
Journal of psychiatry & neuroscience : JPN 2009;34(4):272-80.
2009: Blier Pierre; Gobbi Gabriella; Turcotte Julie E; de Montigny Claude; Boucher Nathalie; Hébert Chantal; Debonnel Guy
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(7):457-65.
2009: Dremencov Eliyahu; El Mansari Mostafa; Blier Pierre
Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.
Journal of psychiatry & neuroscience : JPN 2009;34(3):223-9.
2009: Chenu Franck; El Mansari Mostafa; Blier Pierre
Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(4):475-85.
2009: Manta Stella; Dong Jianming; Debonnel Guy; Blier Pierre
Optimization of vagus nerve stimulation parameters using the firing activity of serotonin neurons in the rat dorsal raphe.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(4):250-5.
2009: Ghanbari Ramez; El Mansari Mostafa; Shahid Mohammed; Blier Pierre
Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(3):177-87.
2009: Chernoloz O; El Mansari M; Blier P
Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(3):651-61.
2009: Blier Pierre
Optimal use of antidepressants: when to act?
Journal of psychiatry & neuroscience : JPN 2009;34(1):80.
2008: Haddjeri Nasser; Blier Pierre
Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions.
European journal of pharmacology 2008;600(1-3):64-70.
2008: El Mansari Mostafa; Ghanbari Ramez; Janssen Shannon; Blier Pierre
Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
Neuropharmacology 2008;55(7):1191-8.
2008: Guiard Bruno P; El Mansari Mostafa; Blier Pierre
Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus.
Molecular pharmacology 2008;74(5):1463-75.
2008: Blier P
Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development.
Journal of psychopharmacology (Oxford, England) 2008;22(6):587-9.
2008: Guiard Bruno P; El Mansari Mostafa; Merali Zul; Blier Pierre
Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(5):625-39.
2008: Blier Pierre
Do antidepressants really work?
Journal of psychiatry & neuroscience : JPN 2008;33(2):89-90.
2008: Trivedi Madhukar H; Hollander Eric; Nutt David; Blier Pierre
Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
The Journal of clinical psychiatry 2008;69(2):246-58.
2008: El Mansari M; Blier P
In vivo electrophysiological assessment of the putative antidepressant Wf-516 in the rat raphe dorsalis, locus coeruleus and hippocampus.
Naunyn-Schmiedeberg's archives of pharmacology 2008;376(5):351-61.
2007: Montgomery Stuart A; Baldwin David S; Blier Pierre; Fineberg Naomi A; Kasper Siegfried; Lader Malcolm; Lam Raymond W; Lépine Jean-Pierre; Möller Hans-Jürgen; Nutt David J; Rouillon Frederic; Schatzberg Alan F; Thase Michael E
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
International clinical psychopharmacology 2007;22(6):323-9.
2007: Dremencov Eliyahu; El Mansari Mostafa; Blier Pierre
Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.
Psychopharmacology 2007;194(1):63-72.
2007: Blier Pierre
Generic medications: another variable in the treatment of illnesses.
Journal of psychopharmacology (Oxford, England) 2007;21(5):459-60.
2007: Blier Pierre
The usefulness of large studies in psychopharmacology: understanding their strong points and their drawbacks.
Journal of psychiatry & neuroscience : JPN 2007;32(4):232-3.
2007: Weiss Michel; Blier Pierre; de Montigny Claude
Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus.
Life sciences 2007;81(2):166-76.
2007: Gobbi Gabriella; Cassano Tommaso; Radja Fatiha; Morgese Maria Grazia; Cuomo Vincenzo; Santarelli Luca; Hen René; Blier Pierre
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(5):328-38.
2007: Blier Pierre; Keller Martin B; Pollack Mark H; Thase Michael E; Zajecka John M; Dunner David L
Preventing recurrent depression: long-term treatment for major depressive disorder.
The Journal of clinical psychiatry 2007;68(3):e06.
2007: Dremencov Eliyahu; El Mansari Mostafa; Blier Pierre
Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain.
Biological psychiatry 2007;61(5):671-8.
2007: Flament Martine F; Geller Dan; Irak Metehan; Blier Pierre
Specificities of treatment in pediatric obsessive-compulsive disorder.
CNS spectrums 2007;12(2 Suppl 3):43-58.
2007: Debonnel Guy; Saint-André Elise; Hébert Chantal; de Montigny Claude; Lavoie Normand; Blier Pierre
Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(1):51-61.
2007: Blier Pierre; Saint-André Elise; Hébert Chantal; de Montigny Claude; Lavoie Normand; Debonnel Guy
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(1):41-50.
2007: Côté Guillaume; Perry Guy; Blier Pierre; Bernatchez Louis
The influence of gene-environment interactions on GHR and IGF-1 expression and their association with growth in brook charr, Salvelinus fontinalis (Mitchill).
BMC genetics 2007;8():87.
2006: Blier Pierre
Psychopharmacology for the clinician. Treating depression with selective norepinephrine reuptake inhibitors.
Journal of psychiatry & neuroscience : JPN 2006;31(4):288.
2006: Blier Pierre
Pregnancy, depression, antidepressants and breast-feeding.
Journal of psychiatry & neuroscience : JPN 2006;31(4):226-8.
2006: Blier Pierre
Media pressure and patient care.
Journal of psychopharmacology (Oxford, England) 2006;20(4):469-70.
2006: Blier Pierre; Habib Rami; Flament Martine F
Pharmacotherapies in the management of obsessive-compulsive disorder.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2006;51(7):417-30.
2006: El Mansari Mostafa; Blier Pierre
Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(3):362-73.
2006: Tremblay Philippe; Blier Pierre
Catecholaminergic strategies for the treatment of major depression.
Current drug targets 2006;7(2):149-58.
2006: Schatzberg Alan F; Blier Pierre; Delgado Pedro L; Fava Maurizio; Haddad Peter M; Shelton Richard C
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research.
The Journal of clinical psychiatry 2006;67 Suppl 4():27-30.
2006: Blier Pierre; Tremblay Philippe
Physiologic mechanisms underlying the antidepressant discontinuation syndrome.
The Journal of clinical psychiatry 2006;67 Suppl 4():8-13.
2005: Gobbi Gabriella; Blier Pierre
Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs.
Peptides 2005;26(8):1383-93.
2005: Blier Pierre
On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders.
Journal of psychiatry & neuroscience : JPN 2005;30(4):304.
2005: El Mansari Mostafa; Blier Pierre
Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition.
Journal of psychiatry & neuroscience : JPN 2005;30(4):268-74.
2005: Blier Pierre
Atypical antipsychotics for mood and anxiety disorders: safe and effective adjuncts?
Journal of psychiatry & neuroscience : JPN 2005;30(4):232-3.
2005: Blier Pierre; Szabo Steve T
Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
The Journal of clinical psychiatry 2005;66 Suppl 8():30-40.
2004: Haddjeri Nasser; Faure Céline; Lucas Guillaume; Mnie-Filali Ouissame; Chouvet Guy; Astier Bernadette; Renaud Bernard; Blier Pierre; Debonnel Guy
In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(4):391-9.
2004: Haddjeri Nasser; Lavoie Normand; Blier Pierre
Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(10):1800-6.
2004: Blier Pierre
How many good antidepressant medications have we missed?
Journal of psychiatry & neuroscience : JPN 2004;29(4):248-9.
2004: Rosa-Neto Pedro; Diksic Mirko; Okazawa Hidehiko; Leyton Marco; Ghadirian Nayyer; Mzengeza Shadreck; Nakai Akio; Debonnel Guy; Blier Pierre; Benkelfat Chawki
Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression.
Archives of general psychiatry 2004;61(6):556-63.
2004: Blier Pierre; Gobbi Gabriella; Haddjeri Nasser; Santarelli Luca; Mathew Gina; Hen René
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.
Journal of psychiatry & neuroscience : JPN 2004;29(3):208-18.
2004: Szabo Steven T; Gold Mark S; Goldberger Bruce A; Blier Pierre
Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons.
Biological psychiatry 2004;55(9):934-9.
2004: Shapira Nathan A; Ward Herbert E; Mandoki Miguel; Murphy Tanya K; Yang Mark C K; Blier Pierre; Goodman Wayne K
A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder.
Biological psychiatry 2004;55(5):553-5.
2003: Gobbi Gabriella; Slater Susan; Boucher Nathalie; Debonnel Guy; Blier Pierre
Neurochemical and psychotropic effects of bupropion in healthy male subjects.
Journal of clinical psychopharmacology 2003;23(3):233-9.
2003: Blier Pierre
Brand versus generic medications: the money, the patient and the research.
Journal of psychiatry & neuroscience : JPN 2003;28(3):167-8.
2003: Zghoul Tarek; Blier Pierre
Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(1):13-21.
2003: Blier Pierre
The pharmacology of putative early-onset antidepressant strategies.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2003;13(2):57-66.
2003: Blier Pierre; Ward Nick M
Is there a role for 5-HT1A agonists in the treatment of depression?
Biological psychiatry 2003;53(3):193-203.
2002: Szabo Steven T; Blier Pierre
Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons.
The Journal of pharmacology and experimental therapeutics 2002;302(3):983-91.
2002: Montgomery Stuart A; Bech Per; Blier Pierre; Möller Hans-Jürgen; Nierenberg Andrew A; Pinder Roger M; Quitkin Frederic M; Reimitz Paul-Egbert; Rosenbaum Jerrold F; Rush A John; Stassen H H; Thase Michael E
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Blier Pierre; Seletti Bernard; Gilbert Francois; Young Simon N; Benkelfat Chawki
Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(2):301-8.
2002: Blier Pierre
Why treat depression differently from other medical problems?
Journal of psychiatry & neuroscience : JPN 2002;27(4):231-2.
2002: Stockmeier Craig A; Shi Xiaochun; Konick Lisa; Overholser James C; Jurjus George; Meltzer Herbert Y; Friedman Lee; Blier Pierre; Rajkowska Grazyna
Neurokinin-1 receptors are decreased in major depressive disorder.
Neuroreport 2002;13(9):1223-7.
2002: Tohyama Yoshihiro; Yamane Fumitaka; Fikre Merid Maraki; Blier Pierre; Diksic Mirko
Effects of serotine receptors agonists, TFMPP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study.
Journal of neurochemistry 2002;80(5):788-98.
2002: Blier Pierre; Ward Herbert
Toward optimal treatments for major depression.
CNS spectrums 2002;7(2):148-50, 153-4.
2002: Richer Maxime; Hen René; Blier Pierre
Modification of serotonin neuron properties in mice lacking 5-HT1A receptors.
European journal of pharmacology 2002;435(2-3):195-203.
2002: Santarelli Luca; Gobbi Gabriella; Blier Pierre; Hen René
Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).
The Journal of clinical psychiatry 2002;63 Suppl 11():11-7.
2001: Szabo S T; Blier P
Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(6):845-57.
2001: Szabo S T; Blier P
Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus.
Synapse (New York, N.Y.) 2001;42(4):203-12.
2001: Szabo S T; Blier P
Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.
Brain research 2001;922(1):9-20.
2001: Yamane F; Okazawa H; Blier P; Diksic M
Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with alpha-[14C]methyl-L-tryptophan(2).
Biochemical pharmacology 2001;62(11):1481-9.
2001: Szabo S T; Blier P
Response of the norepinephrine system to antidepressant drugs.
CNS spectrums 2001;6(8):679-84.
2001: Haddjeri N; Blier P
Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission.
Biological psychiatry 2001;50(3):191-9.
2001: Szabo S T; Blier P
Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons.
The European journal of neuroscience 2001;13(11):2077-87.
2001: Leyton M; Okazawa H; Diksic M; Paris J; Rosa P; Mzengeza S; Young S N; Blier P; Benkelfat C
Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder.
The American journal of psychiatry 2001;158(5):775-82.
2001: Turcotte J E; Debonnel G; de Montigny C; Hébert C; Blier P
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):511-21.
2001: Dong J; Blier P
Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment.
Psychopharmacology 2001;155(1):52-7.
2001: Gobbi G; Murphy D L; Lesch K; Blier P
Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.
The Journal of pharmacology and experimental therapeutics 2001;296(3):987-95.
2001: Santarelli L; Gobbi G; Debs P C; Sibille E T; Blier P; Hen R; Heath M J
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(4):1912-7.
2001: Blier P; Abbott F V
Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.
Journal of psychiatry & neuroscience : JPN 2001;26(1):37-43.
2001: Blier P
Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response.
Journal of psychiatry & neuroscience : JPN 2001;26 Suppl():S3-10.
2001: Blier P
Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles.
Journal of psychiatry & neuroscience : JPN 2001;26 Suppl():S1-2.
2001: Blier P
Pharmacology of rapid-onset antidepressant treatment strategies.
The Journal of clinical psychiatry 2001;62 Suppl 15():12-7.
2001: Blier P
Possible neurobiological mechanisms underlying faster onset of antidepressant action.
The Journal of clinical psychiatry 2001;62 Suppl 4():7-11; discussion 37-40.
2000: Haddjeri N; Lucas G; Blier P
Role of cholinergic and GABAergic systems in the feedback inhibition of dorsal raphe 5-HT neurons.
Neuroreport 2000;11(15):3397-401.
2000: Béïque J C; Blier P; de Montigny C; Debonnel G
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(3):294-306.
2000: Béïque J; de Montigny C; Blier P; Debonnel G
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Neuropharmacology 2000;39(10):1813-22.
2000: Béïque J; de Montigny C; Blier P; Debonnel G
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Neuropharmacology 2000;39(10):1800-12.
2000: Rueter L E; Tecott L H; Blier P
In vivo electrophysiological examination of 5-HT2 responses in 5-HT2C receptor mutant mice.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(5):484-91.
2000: Besson A; Haddjeri N; Blier P; de Montigny C
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(3):177-88.
2000: Haddjeri N; Blier P
Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons.
Neuroreport 2000;11(6):1323-7.
2000: Haddjeri N; Szabo S T; de Montigny C; Blier P
Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(4):346-56.
2000: Tsuiki K; Blier P; Diksic M
Effect of the beta-adrenoceptor agonist flerobuterol on serotonin synthesis in the rat brain.
Biochemical pharmacology 2000;59(6):673-9.
2000: Leyton M; Young S N; Pihl R O; Etezadi S; Lauze C; Blier P; Baker G B; Benkelfat C
Effects on mood of acute phenylalanine/tyrosine depletion in healthy women.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(1):52-63.
2000: Leyton M; Ghadirian A M; Young S N; Palmour R M; Blier P; Helmers K F; Benkelfat C
Depressive relapse following acute tryptophan depletion in patients with major depressive disorder.
Journal of psychopharmacology (Oxford, England) 2000;14(3):284-7.
1999: Dong J; De Montigny C; Blier P
Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Synapse (New York, N.Y.) 1999;34(4):277-89.
1999: de Montigny C; Silverstone P H; Debonnel G; Blier P; Bakish D
Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial.
Journal of clinical psychopharmacology 1999;19(5):401-6.
1999: Haddjeri N; Ortemann C; de Montigny C; Blier P
Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9(5):427-40.
1999: Piñeyro G; Blier P
Autoregulation of serotonin neurons: role in antidepressant drug action.
Pharmacological reviews 1999;51(3):533-91.
1999: Blier P; de Montigny C
Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(2 Suppl):91S-98S.
1999: Béïque J C; de Montigny C; Blier P; Debonnel G
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
Synapse (New York, N.Y.) 1999;32(3):198-211.
1999: Haddjeri N; de Montigny C; Blier P
Modulation of the firing activity of rat serotonin and noradrenaline neurons by (+/-)pindolol.
Biological psychiatry 1999;45(9):1163-9.
1999: Okazawa H; Yamane F; Blier P; Diksic M
Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain.
Journal of neurochemistry 1999;72(5):2022-31.
1999: Bergqvist P B; Dong J; Blier P
Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
Psychopharmacology 1999;143(1):89-96.
1999: Rueter L E; Blier P
Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain.
British journal of pharmacology 1999;126(3):627-38.
1999: Szabo S T; de Montigny C; Blier P
Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers.
British journal of pharmacology 1999;126(3):568-71.
1999: Bergqvist P B; Bouchard C; Blier P
Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder.
Biological psychiatry 1999;45(2):164-74.
1998: Haddjeri N; Blier P; de Montigny C
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.
Journal of affective disorders 1998;51(3):255-66.
1998: Béïque J C; Debonnel G; de Montigny C; Blier P
Discrepancies between the in vitro and in vivo 5-HT and norepinephrine re-uptake blocking properties of venlafaxine.
Annals of the New York Academy of Sciences 1998;861():290-1.
1998: Blier P; Piñeyro G; el Mansari M; Bergeron R; de Montigny C
Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.
Annals of the New York Academy of Sciences 1998;861():204-16.
1998: Haddjeri N; Blier P; de Montigny C
Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(23):10150-6.
1998: Ramboz S; Oosting R; Amara D A; Kung H F; Blier P; Mendelsohn M; Mann J J; Brunner D; Hen R
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14476-81.
1998: Haddjeri N; Seletti B; Gilbert F; de Montigny C; Blier P
Effect of ergotamine on serotonin-mediated responses in the rodent and human brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(5):365-80.
1998: Béïque J C; de Montigny C; Blier P; Debonnel G
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
British journal of pharmacology 1998;125(3):526-32.
1998: Blier P; de Montigny C
Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
Biological psychiatry 1998;44(5):313-23.
1998: Dong J; de Montigny C; Blier P
Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
The Journal of pharmacology and experimental therapeutics 1998;286(3):1239-47.
1998: Rueter L E; de Montigny C; Blier P
In vivo electrophysiological assessment of the agonistic properties of flibanserin at pre- and postsynaptic 5-HT1A receptors in the rat brain.
Synapse (New York, N.Y.) 1998;29(4):392-405.
1998: Mongeau R; Weiss M; de Montigny C; Blier P
Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
Neuropharmacology 1998;37(7):905-18.
1998: Rueter L E; Kasamo K; de Montigny C; Blier P
Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1998;357(6):600-10.
1998: Blier P; Slater S; Measham T; Koch M; Wiviott G
Lithium and clozapine-induced neutropenia/agranulocytosis.
International clinical psychopharmacology 1998;13(3):137-40.
1998: Rueter L E; De Montigny C; Blier P
Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
The Journal of pharmacology and experimental therapeutics 1998;285(2):404-12.
1998: Haddjeri N; De Montigny C; Curet O; Blier P
Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.
European journal of pharmacology 1998;343(2-3):179-92.
1998: Blier P; Bergeron R
The use of pindolol to potentiate antidepressant medication.
The Journal of clinical psychiatry 1998;59 Suppl 5():16-23; discussion 24-5.
1997: Dong J; de Montigny C; Blier P
Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(3):303-11.
1997: Blier P; Bergeron R
Early onset of therapeutic action in depression and greater efficacy of antidepressant treatments: are they related?
International clinical psychopharmacology 1997;12 Suppl 3():S21-8.
1997: Nishizawa S; Benkelfat C; Young S N; Leyton M; Mzengeza S; de Montigny C; Blier P; Diksic M
Differences between males and females in rates of serotonin synthesis in human brain.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(10):5308-13.
1997: Blier P; Bergeron R; de Montigny C
Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(5):333-8.
1997: el Mansari M; Blier P
In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex.
Neuropharmacology 1997;36(4-5):577-88.
1997: Leyton M; Young S N; Blier P; Ellenbogen M A; Palmour R M; Ghadirian A M; Benkelfat C
The effect of tryptophan depletion on mood in medication-free, former patients with major affective disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(4):294-7.
1997: Haddjeri N; de Montigny C; Blier P
Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
British journal of pharmacology 1997;120(5):865-75.
1997: Haddjeri N; Blier P; de Montigny C
Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission.
Naunyn-Schmiedeberg's archives of pharmacology 1997;355(1):20-9.
1996: el Mansari M; Blier P
Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex.
British journal of pharmacology 1996;118(3):681-9.
1996: Haddjeri N; Blier P; de Montigny C
Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
The Journal of pharmacology and experimental therapeutics 1996;277(2):861-71.
1996: Kasamo K; Blier P; De Montigny C
Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
The Journal of pharmacology and experimental therapeutics 1996;277(1):278-86.
1996: Hadrava V; Blier P; de Montigny C
Partial agonistic activity of R- and S-enantiomers of 8-OH-DPAT at 5-HT1A receptors.
Journal of psychiatry & neuroscience : JPN 1996;21(2):101-8.
1996: Blier P; Bergeron R
Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings.
International clinical psychopharmacology 1996;11(1):37-44.
1996: Piñeyro G; Blier P
Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration.
The Journal of pharmacology and experimental therapeutics 1996;276(2):697-707.
1996: Piñeyro G; de Montigny C; Weiss M; Blier P
Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
Synapse (New York, N.Y.) 1996;22(1):54-62.
1996: Abbott F V; Hong Y; Blier P
Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators.
Neuropharmacology 1996;35(1):99-110.
1995: Haddjeri N; Blier P; de Montigny C
Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
International clinical psychopharmacology 1995;10 Suppl 4():11-7.
1995: Piñeyro G; Castanon N; Hen R; Blier P
Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice.
Neuroreport 1995;7(1):353-9.
1995: Piñeyro G; de Montigny C; Blier P
5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;13(3):249-60.
1995: Seletti B; Benkelfat C; Blier P; Annable L; Gilbert F; de Montigny C
Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;13(2):93-104.
1995: el Mansari M; Bouchard C; Blier P
Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;13(2):117-27.
1995: Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
Neuropharmacology 1995;34(10):1311-26.
1995: Blier P; Bergeron R
Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.
Journal of clinical psychopharmacology 1995;15(3):217-22.
1995: Haddjeri N; Blier P
Pre- and post-synaptic effects of the 5-HT3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain.
Synapse (New York, N.Y.) 1995;20(1):54-67.
1995: Blier P; Bergeron R
The safety of concomitant use of sumatriptan and antidepressant treatments.
Journal of clinical psychopharmacology 1995;15(2):106-9.
1995: Piñeyro G; Deveault L; de Montigny C; Blier P
Effect of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe.
Naunyn-Schmiedeberg's archives of pharmacology 1995;351(2):119-25.
1995: Piñeyro G; Deveault L; Blier P; Dennis T; de Montigny C
Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1995;351(2):111-8.
1994: Mongeau R; De Montigny C; Blier P
Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus.
European journal of pharmacology 1994;271(1):121-9.
1994: Blier P; Bouchard C
Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
British journal of pharmacology 1994;113(2):485-95.
1994: Bergeron R; Blier P
Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors.
The American journal of psychiatry 1994;151(7):1084-6.
1994: Hadrava V; Blier P; de Montigny C
Agonist occupation of serotonin1A receptors in the rat hippocampus prevents their inactivation by pertussis toxin.
Neuroscience 1994;61(1):21-30.
1994: Blier P; de Montigny C
Current advances and trends in the treatment of depression.
Trends in pharmacological sciences 1994;15(7):220-6.
1994: Mongeau R; de Montigny C; Blier P
Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission.
The Journal of pharmacology and experimental therapeutics 1994;269(3):1152-9.
1994: Piñeyro G; Blier P; Dennis T; de Montigny C
Desensitization of the neuronal 5-HT carrier following its long-term blockade.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1994;14(5 Pt 2):3036-47.
1994: Mongeau R; De Montigny C; Blier P
Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
European journal of pharmacology 1994;256(3):269-79.
1994: Mongeau R; de Montigny C; Blier P
Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;10(1):41-51.
1993: Dennis T; Blier P; de Montigny C
Delayed effects of spiperone on serotonin1A receptors in the dorsal hippocampus of rats.
Journal of psychiatry & neuroscience : JPN 1993;18(5):264-75.
1993: Blier P; Monroe P J; Bouchard C; Smith D L; Smith D J
5-HT3 receptors which modulate [3H]5-HT release in the guinea pig hypothalamus are not autoreceptors.
Synapse (New York, N.Y.) 1993;15(2):143-8.
1993: Blier P; Lista A; De Montigny C
Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
The Journal of pharmacology and experimental therapeutics 1993;265(1):7-15.
1993: Blier P; Lista A; De Montigny C
Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.
The Journal of pharmacology and experimental therapeutics 1993;265(1):16-23.
1993: Mongeau R; Blier P; de Montigny C
In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus.
Naunyn-Schmiedeberg's archives of pharmacology 1993;347(3):266-72.
1993: Blier P; Bouchard C
Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain.
British journal of pharmacology 1993;108(1):13-22.
1992: Curet O; De Montigny C; Blier P
Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
European journal of pharmacology 1992;221(1):59-70.
1992: Monnet F P; Blier P; Debonnel G; de Montigny C
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency.
Naunyn-Schmiedeberg's archives of pharmacology 1992;346(1):32-9.
1992: Blier P; Bouchard C
Effect of repeated electroconvulsive shocks on serotonergic neurons.
European journal of pharmacology 1992;211(3):365-73.
1992: Blier P; de Montigny C
Electrophysiological studies on the heterogeneity of 5-HT1A receptors: psychopharmacological implications.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():137A-138A.
1992: de Montigny C; Blier P
Potentiation of 5-HT neurotransmission by short-term lithium: in vivo electrophysiological studies.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():610A-611A.
1991: Chaput Y; de Montigny C; Blier P
Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1991;5(4):219-29.
1991: Blier P
Terminal serotonin autoreceptor function in the rat hippocampus is not modified by pertussis and cholera toxins.
Naunyn-Schmiedeberg's archives of pharmacology 1991;344(2):160-6.
1991: Blier P; Curet O; Chaput Y; de Montigny C
Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
Neuropharmacology 1991;30(7):691-701.
1991: Godbout R; Chaput Y; Blier P; de Montigny C
Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
Neuropharmacology 1991;30(7):679-90.
1991: Lacroix D; Blier P; Curet O; de Montigny C
Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
The Journal of pharmacology and experimental therapeutics 1991;257(3):1081-90.
1991: Bouthillier A; Blier P; de Montigny C
Flerobuterol, a beta-adrenoceptor agonist, enhances serotonergic neurotransmission: an electrophysiological study in the rat brain.
Psychopharmacology 1991;103(3):357-65.
1990: de Montigny C; Chaput Y; Blier P
Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers.
The Journal of clinical psychiatry 1990;51 Suppl B():4-8.
1990: Lista A; Blier P; de Montigny C
Benzodiazepine receptors modulating serotonergic neurotransmission in rat hippocampus do not desensitize after long-term diazepam treatment.
Brain research 1990;526(1):161-4.
1990: Lista A; Blier P; de Montigny C
Benzodiazepine receptors modulate 5-hydroxytryptamine neurotransmission in the rat hippocampus: in vivo electrophysiological evidence.
The Journal of pharmacology and experimental therapeutics 1990;254(1):318-23.
1990: Blier P; de Montigny C
Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies.
Journal of clinical psychopharmacology 1990;10(3 Suppl):13S-20S.
1990: Blier P; de Montigny C; Chaput Y
A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.
The Journal of clinical psychiatry 1990;51 Suppl():14-20; discussion 21.
1990: Lista A; Blier P; De Montigny C
The benzodiazepine receptor inverse agonist DMCM decreases serotonergic transmission in rat hippocampus: an in vivo electrophysiological study.
Synapse (New York, N.Y.) 1990;6(2):175-8.
1990: Blier P; de Montigny C
Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists.
Journal of cardiovascular pharmacology 1990;15 Suppl 7():S42-8.
1989: Lista A; Blier P; De Montigny C
In vivo presynaptic modulation of serotonergic neurotransmission in the rat hippocampus by diazepam.
European journal of pharmacology 1989;171(2-3):229-31.
1989: Blier P; Steinberg S; Chaput Y; de Montigny C
Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus.
Canadian journal of physiology and pharmacology 1989;67(2):98-105.
1988: Blier P; Chaput Y; de Montigny C
Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(3):246-54.
1988: Blier P; de Montigny C; Chaput Y
Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission.
Clinical neuropharmacology 1988;11 Suppl 2():S1-10.

Sign-in to see more